Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | EDIT | CCCC | ||
| Company | Fate Therapeutics | Editas Medicine | C4 Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.88 | 5.25 | 6.30 | ||
| High | 3.95 | 5.39 | 6.37 | ||
| Low | 3.74 | 5.13 | 6.12 | ||
| Last | 3.80 | 5.32 | 6.17 | ||
| Change | -0.07 | +0.10 | -0.07 | ||
| % Change | -1.81% | +1.92% | -1.12% | ||
| Volume | 2,732,200 | 1,352,100 | 1,047,700 | ||
| 20-Day Average Volume | 2,268,495 | 1,703,715 | 1,269,545 | ||
| Previous Close | 3.87 | 5.22 | 6.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.68 | 6.16 | 7.22 | ||
| 20-Day Raw Stochastic | 1.66% | 9.13% | 2.30% | ||
| 20-Day Relative Strength | 26.89% | 30.63% | 35.64% | ||
| Weighted Alpha | -60.01 | -60.64 | -43.56 | ||
| Today's Opinion | 8% Sell | 100% Sell | 24% Buy | ||
| Previous Opinion | 8% Sell | 88% Sell | 24% Buy | ||
| Last Month's Opinion | 80% Buy | 72% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.67% since 04/19/24 | -3.10% since 04/19/24 | -8.18% since 04/19/24 | ||
| Low | 3.74 on 04/26/24 | 5.11 on 04/25/24 | 6.12 on 04/26/24 | ||
| High | 5.02 on 04/23/24 | 5.92 on 04/23/24 | 7.15 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -44.61% since 03/26/24 | -26.32% since 03/26/24 | -22.29% since 03/26/24 | ||
| Low | 3.74 on 04/26/24 | 5.11 on 04/25/24 | 6.12 on 04/26/24 | ||
| High | 7.65 on 03/28/24 | 7.53 on 03/27/24 | 8.29 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -16.67% since 01/26/24 | -27.02% since 01/26/24 | +12.80% since 01/26/24 | ||
| Low | 3.74 on 04/26/24 | 5.11 on 04/25/24 | 5.00 on 02/05/24 | ||
| High | 8.83 on 03/07/24 | 11.58 on 02/28/24 | 11.88 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | +117.14% since 10/26/23 | -18.28% since 10/26/23 | +331.47% since 10/26/23 | ||
| Low | 1.63 on 10/30/23 | 5.11 on 04/25/24 | 1.06 on 12/06/23 | ||
| High | 8.83 on 03/07/24 | 11.69 on 12/06/23 | 11.88 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 432,505 | 437,490 | 423,268 | ||
| Shares Outstanding, K | 113,817 | 82,235 | 68,601 | ||
| Annual Sales | 63,530,000 | 78,120,000 | 20,760,000 | ||
| Annual Net Income | -160,930,000 | -153,220,000 | -132,490,000 | ||
| Last Quarter Sales | 1,680,000 | 60,050,000 | 3,260,000 | ||
| Last Quarter Net Income | -44,120,000 | -18,870,000 | -34,750,000 | ||
| 60-Month Beta | 1.66 | 2.01 | 3.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 02/26/24 | -0.23 on 02/28/24 | -0.68 on 02/22/24 | ||
| Latest Earnings Date | 05/01/24 | 05/03/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||